Author | Elizabeth S. Waxman, RN, MSN, NP-C


Current Treatment Options for Non–Small-Cell Lung Cancer

August 27, 2012

Chemotherapy is now employed in earlier-stage disease in neoadjuvant, adjuvant, and combined-modality treatments. The aim of this article is to review the current systemic treatments for NSCLC.

An Infusion Reaction to Cetuximab

April 18, 2011

Hypersensitivity/infusion reactions can be caused by monoclonal antibodies and chemotherapeutic agents. Immediate interventions are often required.